{"organizations": [], "uuid": "57c75d7a06d1bd73f374f7694e3cb70f0ecc0641", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-beigene-announces-approval-of-revl/brief-beigene-announces-approval-of-revlimid-in-china-idUSFWN1QH1GG", "country": "US", "domain_rank": 408, "title": "BRIEF-Beigene Announces Approval Of Revlimid In China", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T01:10:00.000+02:00", "replies_count": 0, "uuid": "57c75d7a06d1bd73f374f7694e3cb70f0ecc0641"}, "author": "", "url": "https://www.reuters.com/article/brief-beigene-announces-approval-of-revl/brief-beigene-announces-approval-of-revlimid-in-china-idUSFWN1QH1GG", "ord_in_thread": 0, "title": "BRIEF-Beigene Announces Approval Of Revlimid In China", "locations": [], "entities": {"persons": [{"name": "revlimid", "sentiment": "none"}], "locations": [{"name": "china", "sentiment": "none"}, {"name": "china", "sentiment": "none"}], "organizations": [{"name": "brief-beigene announces approval of revlimid in china reuters", "sentiment": "negative"}, {"name": "beigene ltd", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Beigene Ltd:\n* BEIGENE ANNOUNCES APPROVAL OF REVLIMID® FOR NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINA\n* BEIGENE LTD - ‍REVLIMID HAS BEEN APPROVED BY CHINA FOOD AND DRUG ADMINISTRATION FOR TREATMENT OF MULTIPLE MYELOMA​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-28T01:10:00.000+02:00", "crawled": "2018-02-28T01:25:19.001+02:00", "highlightTitle": ""}